Cargando…

Erratum to: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Detalles Bibliográficos
Autores principales:	Gluba-Brzózka, Anna, Michalska-Kasiczak, Marta, Franczyk, Beata, Nocuń, Marek, Toth, Peter P., Banach, Maciej, Rysz, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804534/ https://www.ncbi.nlm.nih.gov/pubmed/27004696 http://dx.doi.org/10.1186/s12944-016-0230-7

Ejemplares similares

Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study
por: Gluba-Brzózka, Anna, et al.
Publicado: (2016)

Markers of increased cardiovascular risk in patients with chronic kidney disease
por: Gluba-Brzózka, Anna, et al.
Publicado: (2014)

Emerging Anti-Atherosclerotic Therapies
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021)

The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016)

Vegetarian Diet in Chronic Kidney Disease—A Friend or Foe
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases
por: Gluba-Brzózka, Anna, et al.
Publicado: (2017)

The Effect of Diet on the Survival of Patients with Chronic Kidney Disease
por: Rysz, Jacek, et al.
Publicado: (2017)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020)

The Influence of Dietary Interventions on Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
por: Rysz, Jacek, et al.
Publicado: (2021)

Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013)

Novel Biomarkers in the Diagnosis of Chronic Kidney Disease and the Prediction of Its Outcome
por: Rysz, Jacek, et al.
Publicado: (2017)

Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients
por: Gluba-Brzozka, Anna, et al.
Publicado: (2019)

Pharmacogenetics of Drugs Used in the Treatment of Cancers
por: Franczyk, Beata, et al.
Publicado: (2022)

Impact of Vitamin D on the Cardiovascular System in Advanced Chronic Kidney Disease (CKD) and Dialysis Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2018)

Heart function disturbances in chronic kidney disease – echocardiographic indices
por: Franczyk-Skóra, Beata, et al.
Publicado: (2014)

Diabetes and Cardiovascular Risk in Renal Transplant Patients
por: Rysz, Jacek, et al.
Publicado: (2021)

Are Nutraceuticals Beneficial in Chronic Kidney Disease?
por: Rysz, Jacek, et al.
Publicado: (2021)

Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)

Ageing, Age-Related Cardiovascular Risk and the Beneficial Role of Natural Components Intake
por: Rysz, Jacek, et al.
Publicado: (2021)

Are Alterations in DNA Methylation Related to CKD Development?
por: Rysz, Jacek, et al.
Publicado: (2022)

The Role of Inflammation and Oxidative Stress in Rheumatic Heart Disease
por: Franczyk, Beata, et al.
Publicado: (2022)

Prevention of sudden cardiac death in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2012)

Oxidative Stress in ESRD Patients on Dialysis and the Risk of Cardiovascular Diseases
por: Rysz, Jacek, et al.
Publicado: (2020)

The Influence of Inflammation on Anemia in CKD Patients
por: Gluba-Brzózka, Anna, et al.
Publicado: (2020)

Oxidative Stress-Related Susceptibility to Aneurysm in Marfan’s Syndrome
por: Rysz, Jacek, et al.
Publicado: (2021)

Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC)
por: Rysz, Jacek, et al.
Publicado: (2021)

Renal Cell Cancer and Obesity
por: Gluba-Brzózka, Anna, et al.
Publicado: (2022)

Is a High HDL-Cholesterol Level Always Beneficial?
por: Franczyk, Beata, et al.
Publicado: (2021)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
por: Franczyk, Beata, et al.
Publicado: (2023)

The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review
por: Franczyk, Beata, et al.
Publicado: (2023)

High-Sensitivity C-Reactive Protein Relationship with Metabolic Disorders and Cardiovascular Diseases Risk Factors
por: Koziarska-Rościszewska, Małgorzata, et al.
Publicado: (2021)

Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

The Role of Metabolic Factors in Renal Cancers
por: Rysz, Jacek, et al.
Publicado: (2020)

The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma
por: Rysz, Jacek, et al.
Publicado: (2022)

The Impact of CKD on Uremic Toxins and Gut Microbiota
por: Rysz, Jacek, et al.
Publicado: (2021)

miRNA biomarkers in renal disease
por: Franczyk, Beata, et al.
Publicado: (2021)

Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?
por: Franczyk, Beata, et al.
Publicado: (2022)

Pathomechanisms of Immunological Disturbances in β-Thalassemia
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l479hfnnkk3aql3ghld2btd0da